Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-15-020299

VP, Finance sold 1,125 shares at $0.71 ($800)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Selby Brian L. VP, Finance 2015-03-02 Sale −1,125 $0.71 $800 33,441 D: show line 1 in the form
Open-market sales · 1,125 sh · avg $0.71 · $800
Loading xslF345X03/doc4.xml…